Literature DB >> 23799252

Advance directives, control, and quality of life for persons with disabilities.

Deborah L Volker1, Chris Divin-Cosgrove, Tracie Harrison.   

Abstract

BACKGROUND: Personal control over end-of-life (EOL) care via advance care planning is a key component of high-quality care. Although this desire for control has been well documented in some populations, EOL care issues are not well understood within the disabilities community.
OBJECTIVE: The objective for this study was to describe the relationships between individual demographic characteristics, health-related quality of life, health locus of control, and attitudes toward advance directives (ADs) in individuals who are disabilities activists.
METHODS: We surveyed 55 participants attending a disability conference. Instruments included a demographic data sheet, the Advance Directive Attitude Survey (ADAS), the Multidimensional Health Locus of Control scale, and the Functional Assessment of Non-Life Threatening Conditions quality of life (QOL) scale.
RESULTS: Most participants were Hispanic females with some college education. About 46% had a disability. Group means revealed a high level of QOL (M=75.72, SD=19.09) and a positive attitude about ADs (M=66.49, SD=8.03). On the Opportunities for Treatment Choices subscale of the ADAS, activists without disabilities (M=14.23) were more positive about their control over EOL decisions than were the activists with disabilities (M=12.97) [t(2,52)=2.116, p<0.05].
CONCLUSIONS: Although participants were positive about ADs, differences in attitudes about control over opportunities for treatment choices between the nondisabled and disabled groups support previous findings that people with disabilities may have concerns regarding undertreatment for serious health conditions. Further study of EOL care issues for persons with disabilities is warranted.

Entities:  

Mesh:

Year:  2013        PMID: 23799252     DOI: 10.1089/jpm.2013.0008

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  3 in total

1.  The relationship between liver cyst volume and QOL in Japanese ADPKD patients.

Authors:  Satoru Muto; Masahiko Ando; Saori Nishio; Kazushige Hanaoka; Yoshifumi Ubara; Ichiei Narita; Kouichi Kamura; Toshio Mochizuki; Ken Tsuchiya; Kazuhiko Tsuruya; Shigeo Horie
Journal:  Clin Exp Nephrol       Date:  2019-12-26       Impact factor: 2.801

2.  A National Study of Life-Sustaining Treatments in South Korea: What Factors Affect Decision-Making?

Authors:  So-Youn Park; Bomyee Lee; Jeong Yeon Seon; In-Hwan Oh
Journal:  Cancer Res Treat       Date:  2020-11-21       Impact factor: 4.679

3.  Protocol for a national prevalence study of advance care planning documentation and self-reported uptake in Australia.

Authors:  Rasa Ruseckaite; Karen M Detering; Sue M Evans; Veronica Perera; Lynne Walker; Craig Sinclair; Josephine M Clayton; Linda Nolte
Journal:  BMJ Open       Date:  2017-11-03       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.